New pill aims to tame debilitating bowel disease
Disease control
Not yet recruiting
This study is testing a new oral medication, MB-001, for adults with moderate to severe ulcerative colitis (UC). About 100 participants will take either the drug or a placebo pill daily for 12 weeks to see if it safely reduces symptoms and intestinal inflammation. The goal is to …
Phase: PHASE1, PHASE2 • Sponsor: Mage Biologics • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC